What We Heard at ABFO 2026: AI Is the Priority — and Many Don't Know Where to Start

Takeaways from Condor's panel at ABFO 2026 with EY, BridgeBio and Addition Therapeutics.

Condor’s panel at ABFO 2026

Takeaways from Condor's panel at ABFO 2026 with EY, BridgeBio and Addition Therapeutics. The discussion covered where clinical finance teams should begin with AI.

Read the full post on condorsoftware.com

Share

More from Pamir

All stories